What is ECMO Advantage?
ECMO Advantage is a specialized healthcare services organization dedicated to enhancing extracorporeal membrane oxygenation (ECMO) capabilities within hospitals and healthcare systems. The company provides comprehensive support, including program development, clinical training, and the provision of specialized staffing. By offering expert guidance and operational assistance, ECMO Advantage empowers medical institutions to build robust ECMO programs, thereby improving the delivery of advanced cardiopulmonary life-support treatments with enhanced safety and effectiveness.
How much funding has ECMO Advantage raised?
ECMO Advantage has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
What's next for ECMO Advantage?
With its recent large-scale, late-stage funding, ECMO Advantage is poised for significant expansion and further development of its critical care support services. This strategic capital infusion is expected to fuel advancements in its training methodologies and staffing solutions, enabling more healthcare providers to implement and optimize ECMO programs. The company's focus on strengthening hospital infrastructure for advanced life support suggests a trajectory aimed at broader market penetration and enhanced patient outcomes across the healthcare landscape.
See full ECMO Advantage company page
